Relative risk of cardiovascular events in patients with rheumatoid arthritis

The American Journal of Cardiology
Anthony N DeMaria

Abstract

Rheumatoid arthritis (RA) is associated with increased comorbidity and mortality resulting from cardiovascular disease. A review of past and recent studies suggests that inflammation and thrombosis may provide a link between both diseases. This association has significant clinical implications for therapy, because many of the drugs used in the symptomatic treatment of RA, such as nonsteroidal anti-inflammatory drugs and the new cyclooxygenase (COX)-2-specific inhibitors, affect mediators of both inflammation and thrombosis. Recent studies have elucidated the potential effects of COX-2-specific inhibitors on thrombogenic events and their potential impact on cardiovascular disease. Although a causal effect of these drugs to increase the risk of cardiovascular disease has not been established, further investigation is needed on the effects of COX-2-specific inhibitors on cardiovascular risk. Such data would be of particular importance in determining appropriate therapeutic approaches to the treatment of patients with RA who are also at risk for cardiovascular events.

References

Sep 1, 1988·Clinical Rheumatology·T D Spector, D L Scott
Nov 1, 1988·Arthritis and Rheumatism·L F Callahan, T Pincus
Apr 26, 1984·The New England Journal of Medicine·G A FitzGeraldA R Brash
May 1, 1984·British Journal of Rheumatology·P PriorC F Hawkins
Aug 15, 1994·Annals of Internal Medicine·A G JohnsonR O Day
Apr 1, 1994·Arthritis and Rheumatism·F WolfeM A Cathey
Dec 1, 1995·Seminars in Arthritis and Rheumatism·R A Myllykangas-LuosujärviH A Isomäki
Dec 1, 1996·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·E BerkanovicH Paulus
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B F McAdamG A FitzGerald
Nov 26, 1999·Circulation·V Pasceri, E T Yeh
Dec 28, 1999·Annals of the Rheumatic Diseases·J F Fries, D A Bloch
Nov 21, 2000·Rheumatic Diseases Clinics of North America·K S Kanik, R L Wilder
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group
Feb 15, 2001·The American Journal of Medicine·F Catella-Lawson, L J Crofford
Mar 30, 2001·Rheumatology·O Sangha
Jun 9, 2001·Rheumatic Diseases Clinics of North America·T R Mikuls, K G Saag

❮ Previous
Next ❯

Citations

Oct 9, 2003·Current Rheumatology Reports·Robert B M Landewé, Désirée M F M van der Heijde
Jul 3, 2002·The Journal of Clinical Investigation·G A FitzGerald
Feb 2, 2006·Psychosomatic Medicine·Paul E StangRonald C Kessler
Dec 5, 2012·Arthritis·Jorge Cárdenas RoldánJuan-Manuel Anaya
Feb 7, 2013·Journal of Physiology and Biochemistry·Amit Kumar Shrivastava, Aparna Pandey
Feb 28, 2007·Joint, Bone, Spine : Revue Du Rhumatisme·Yannick Allanore
May 26, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Vasiliki V GeorgiopoulouLaurence Sperling
Dec 20, 2014·Proteomics. Clinical Applications·Priscila Camillo TeixeiraPaul Cutler
Jun 15, 2004·Biochemical Pharmacology·Ellen NiederbergerGerd Geisslinger
Oct 3, 2006·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Amit MayerMoshe Mazor
Mar 4, 2008·Journal of the American Dietetic Association·Kathleen Woolf, Melinda M Manore
Sep 17, 2005·Pharmacotherapy·Nigel J Dagenais, Fakhreddin Jamali
Jan 12, 2007·Journal of Clinical Periodontology·Francesco D'AiutoMaurizio S Tonetti
Apr 22, 2008·Expert Opinion on Pharmacotherapy·J Avouac, Y Allanore
Feb 21, 2004·Journal of the American College of Cardiology·Patricia A Howard, Patrice Delafontaine
Feb 27, 2004·The American Journal of Medicine·Frederick Wolfe, Kaleb Michaud
Jul 2, 2014·Arthritis·Abdullah Al-NahainMohammed Rahmatullah
Sep 20, 2011·Rheumatology·Aamer SandooGeorge D Kitas
Apr 1, 2017·Archivum Immunologiae Et Therapiae Experimentalis·Luca MoroniPier Luigi Meroni
Apr 20, 2004·Journal of Cardiovascular Pharmacology and Therapeutics·Wangde Dai, Robert A Kloner
Dec 12, 2003·Nature Reviews. Drug Discovery·Garret A FitzGerald
Oct 7, 2011·The Cochrane Database of Systematic Reviews·Jonathan L MarksChristopher J Edwards
Oct 18, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Garret A Fitzgerald
Aug 30, 2014·The Journal of Biological Chemistry·Priscila Camillo TeixeiraPaul Cutler
Oct 26, 2012·Arthritis·Jenny Amaya-AmayaAdriana Rojas-Villarraga
Nov 30, 2012·Arthritis·Juan Camilo Sarmiento-MonroyAdriana Rojas-Villarraga
Sep 9, 2006·Journal of Clinical Laboratory Analysis·Iván PalomoRicardo Forastiero
Sep 22, 2006·Zeitschrift für Rheumatologie·G WesthoffA Zink
Mar 31, 2010·Nature Reviews. Rheumatology·Faisel KhanJill J F Belch
Aug 10, 2005·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Carsten H MeyerStefan Mennel
Sep 2, 2014·BioMed Research International·Jenny Amaya-AmayaAdriana Rojas-Villarraga
Apr 17, 2009·The Journal of Rheumatology·Carmen García-GómezXavier Pintó
Oct 16, 2016·Journal of Medical Internet Research·Amy Shirong LuTzu-An Chen
Apr 23, 2004·Current Opinion in Rheumatology·Sonja A Dechant, Eric L Matteson
Apr 15, 2010·Rheumatology International·Armen Yuri GasparyanGeorge D Kitas
Feb 25, 2021·Journal of Food Biochemistry·Dhvani SharmaVasanti Suvarna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.